Neurologic toxicities following adoptive immunotherapy with BCMA-directed CAR T cells
Top Cited Papers
- 5 October 2023
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 142 (14) , 1243-1248
Abstract
In 2 complementary Letters to Blood, Karschnia et al and Graham et al provide new insights into the neurological toxicities that are observed with B-cell maturation antigen–directed chimeric antigen receptor T-cell treatment for multiple myeloma, identifying a frequency of immune effector cell–associated neurotoxicity syndrome (ICANS) that exceeds 40%. Severe ICANS is identified in 8% of patients in this real-world series. Outcomes were generally favorable, although the authors describe rare, late Parkinsonism-like hypokinetic movement disorders (also known as movement and neurocognitive toxicities) post-ICANS in 2 patients.Keywords
This publication has 15 references indexed in Scilit:
- Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label studyThe Lancet, 2021
- Idecabtagene Vicleucel in Relapsed and Refractory Multiple MyelomaNew England Journal of Medicine, 2021
- Multiple myelomaThe Lancet, 2021
- Single-Cell Analyses Identify Brain Mural Cells Expressing CD19 as Potential Off-Tumor Targets for CAR-T ImmunotherapiesCell, 2020
- Clinical Predictors of Neurotoxicity After Chimeric Antigen Receptor T-Cell TherapyJAMA Neurology, 2020
- Language dysfunction-associated EEG findings in patients with CAR-T related neurotoxicityBMJ Neurology Open, 2020
- Clinical presentation, management, and biomarkers of neurotoxicity after adoptive immunotherapy with CAR T cellsBlood, 2019
- Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple MyelomaNew England Journal of Medicine, 2019
- Clinical and Biological Correlates of Neurotoxicity Associated with CAR T-cell Therapy in Patients with B-cell Acute Lymphoblastic LeukemiaCancer Discovery, 2018
- EEG findings in CAR T-cell therapy-related encephalopathyNeurology, 2018